Skip to main content

Table 4 Differences in medical cannabis use and side effects experienced by authorization status

From: Canadians’ use of cannabis for therapeutic purposes since legalization of recreational cannabis: a cross-sectional analysis by medical authorization status

 

Currently taking medical cannabis

p-value for difference

With authorization

Without authorization

Types of products participants reported takinga

Dried flower

1917 (66.3%)

1938 (78.8%)

< 0.001

Oils

1978 (68.4%)

1086 (44.2%)

< 0.001

Edibles

1388 (48.0%)

1531 (62.3%)

< 0.001

 Vape

1156 (40.0%)

1052 (42.8%)

0.036

Capsules

1006 (34.8%)

521 (21.2%)

< 0.001

Topical

802 (27.7%)

588 (23.9%)

< 0.001

Concentrates

630 (21.8%)

637 (25.9%)

< 0.001

Oral sprays

506 (17.5%)

276 (11.2%)

< 0.001

Beverages

352 (12.2%)

373 (15.2%)

< 0.001

Oral strips

171 (5.9%)

46 (1.9%)

< 0.001

Suppositories

130 (4.5%)

61 (2.5%)

< 0.001

Reported side effects associated with current medical cannabis consumptionb

 Anxiety

251 (8.7%)

230 (9.4%)

0.006

 Confusion

126 (4.4%)

119 (4.9%)

0.027

Cough

684 (23.7%)

861 (35.1%)

< 0.001

Dependency or addiction to cannabis

105 (3.6%)

264 (10.8%)

< 0.001

Dry mouth

1235 (42.8%)

1168 (47.6%)

< 0.001

 Feeling faint

113 (3.9%)

89 (3.6%)

0.58

 Feeling intoxicated

401 (13.9%)

361 (14.7%)

0.012

Feeling paranoid

170 (5.9%)

208 (8.5%)

< 0.001

 Feeling tired

563 (19.5%)

544 (22.2%)

0.058

 Nausea

68 (2.4%)

62 (2.5%)

0.81

 Rapid heart rate

201 (7.0%)

213 (8.7%)

0.066

 Trouble remembering things

434 (15.0%)

443 (18.1%)

0.011

 Unable to concentrate

216 (7.5%)

189 (7.7%)

0.037

Vomiting

12 (0.4%)

31 (1.3%)

< 0.001

I have not experienced any side effects

861 (29.9%)

573 (23.4%)

< 0.001

  1. aValues are the number of participants who reported taking the medical cannabis product
  2. bValues are N (%), representing the number of participants who reported experiencing the specific side effect